This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.
You May Also Be Interested In
Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
Advisory: Obsessive-Compulsive Disorder and Substance Use Disorders
This advisory discusses the interaction between obsessive-compulsive disorder (OCD) and substance use disorder. It provides clinicians with an overview of screening and evidence-based treatments for OCD.
Treatment of Stimulant Use Disorders
Advisory: An Introduction to Bipolar Disorder and Co-Occurring Substance Use Disorders
This advisory gives an introduction to bipolar disorder and co-occurring substance use disorder. It discusses types of bipolar disorders along with the challenges in screening and treatments.
Screening and Assessment of Co-Occurring Disorders in the Justice System
This report provides evidence-based practices for screening and assessment of adults in the justice system with mental illness, substance use disorders, or both. It discusses the importance of instrument selection for screening and assessment and provides detailed descriptions of recommended instruments.
TIP 56: Addressing the Specific Behavioral Health Needs of Men
This guide addresses specific treatment needs of adult men living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of substance use among men and specific treatment issues and strategies.